What AI says about RoosterBio

RoosterBio supplies human mesenchymal stem/stromal cells (hMSCs) from bone marrow, adipose tissue, umbilical cord, and other sources, along with exosomes, cell banks, and media to enable MSC- and exosome-based therapy development. They offer end-to-end, cGMP-ready products and services, including hMSC expansion media, bioreactor feeds, genetic engineering media, exosome media, downstream processing, and analytical/CMC support to shorten development timelines and lower costs. With a global ecosystem and regulatory expertise, they support hundreds of partners in more than 25 countries, providing QuickShip solutions and scalable platforms to accelerate translation from research to clinic and market.